Published in Am J Ophthalmol on July 09, 2015
Correction of Monogenic and Common Retinal Disorders with Gene Therapy. Genes (Basel) (2017) 0.79
Quantification of Ellipsoid Zone Changes in Retinitis Pigmentosa Using en Face Spectral Domain-Optical Coherence Tomography. JAMA Ophthalmol (2016) 0.76
A Novel Method for Quantitative Serial Autofluorescence Analysis in Retinitis Pigmentosa Using Image Characteristics. Transl Vis Sci Technol (2016) 0.75
Quantifying Fundus Autofluorescence in Patients With Retinitis Pigmentosa. Invest Ophthalmol Vis Sci (2017) 0.75
Quantitative Analysis of Retinal Structure using Spectral Domain Optical Coherence Tomography in RPGR-associated Retinopathy. Am J Ophthalmol (2017) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med (2008) 15.30
Retinitis pigmentosa. Lancet (2006) 13.62
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol (1993) 7.73
Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med (2015) 3.16
Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol (1985) 2.98
Long-term effect of gene therapy on Leber's congenital amaurosis. N Engl J Med (2015) 2.68
A one-hit model of cell death in inherited neuronal degenerations. Nature (2000) 2.65
Test-retest reliability of the multifocal electroretinogram and humphrey visual fields in patients with retinitis pigmentosa. Doc Ophthalmol (2004) 1.94
Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2. Ophthalmology (2013) 1.85
Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol (2004) 1.80
Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology (1999) 1.80
Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol (2006) 1.74
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol (2004) 1.71
Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update. Doc Ophthalmol (2007) 1.56
Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa. Retina (2009) 1.53
Visual acuity loss in retinitis pigmentosa. Relationship to visual field loss. Arch Ophthalmol (1990) 1.52
Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol Vis Sci (2002) 1.49
Rate of visual field loss in retinitis pigmentosa. Ophthalmology (1997) 1.42
Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol (2005) 1.38
Correlation of fundus autofluorescence with photoreceptor morphology and functional changes in eyes with retinitis pigmentosa. Acta Ophthalmol (2010) 1.35
Multifocal electroretinography in retinitis pigmentosa. Am J Ophthalmol (1998) 1.34
Comparison of fundus autofluorescence with photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci (2004) 1.30
Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa. Am J Ophthalmol (2008) 1.27
Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina (2011) 1.25
A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol (2004) 1.24
Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci (2003) 1.23
Kinetics of visual field loss in Usher syndrome Type II. Invest Ophthalmol Vis Sci (2004) 1.22
Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol (2013) 1.20
Rates of change differ among measures of visual function in patients with retinitis pigmentosa. Ophthalmology (1996) 1.19
Changes of fundus autofluorescence, photoreceptor inner and outer segment junction line, and visual function in patients with retinitis pigmentosa. Clin Experiment Ophthalmol (2010) 1.18
Progressive constriction of the hyperautofluorescent ring in retinitis pigmentosa. Am J Ophthalmol (2011) 1.13
Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmology (2003) 1.10
Natural course of visual field loss in patients with Type 2 Usher syndrome. Retina (2007) 1.09
Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene. Invest Ophthalmol Vis Sci (2008) 1.08
A Comparison of Methods for Tracking Progression in X-Linked Retinitis Pigmentosa Using Frequency Domain OCT. Transl Vis Sci Technol (2013) 1.08
Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography. Invest Ophthalmol Vis Sci (2008) 1.07
Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial. Retina (2008) 1.04
Patterns of visual field progression in patients with retinitis pigmentosa. Ophthalmology (1998) 1.02
Vitamin A supplementation for retinitis pigmentosa. Arch Ophthalmol (1993) 1.00
Correlation between macular volume and focal macular electroretinogram in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2008) 1.00
Structural and functional changes associated with normal and abnormal fundus autofluorescence in patients with retinitis pigmentosa. Retina (2012) 0.99
Short-term inter-visit variability of erg amplitudes in normal subjects and patients with retinitis pigmentosa. Retina (2005) 0.97
Serial imaging and structure-function correlates of high-density rings of fundus autofluorescence in retinitis pigmentosa. Retina (2011) 0.96
Correlation between macular morphology and sensitivity in patients with retinitis pigmentosa and hyperautofluorescent ring. Invest Ophthalmol Vis Sci (2012) 0.93
Unilateral retinitis pigmentosa: a proposal of genetic pathogenic mechanisms. Eur J Ophthalmol (2012) 0.93
Fundus autofluorescence and optical coherence tomography in relation to visual function in Usher syndrome type 1 and 2. Vision Res (2012) 0.88
Unilateral retinitis pigmentosa occurring in an individual with a germline mutation in the RP1 gene. Arch Ophthalmol (2011) 0.85
Comparison of fundus autofluorescence with photopic and scotopic fine matrix mapping in patients with retinitis pigmentosa: 4- to 8-year follow-up. Invest Ophthalmol Vis Sci (2012) 0.84
Correlation between optical coherence tomography and multifocal electroretinogram findings with visual acuity in retinitis pigmentosa. Clin Ophthalmol (2013) 0.84
Long-term effects of retinal gene therapy in childhood blindness. N Engl J Med (2015) 0.81
Bilateral symmetry of vision disorders in typical retinitis pigmentosa. Br J Ophthalmol (1979) 0.81
The dose-dependent macular thickness changes assessed by fd-oct in patients with retinitis pigmentosa treated with ciliary neurotrophic factor. Retina (2014) 0.79
Bilateral Concordance of the Fundus Hyperautofluorescent Ring in Typical Retinitis Pigmentosa Patients. Ophthalmic Genet (2013) 0.79
"Do you, doctor, take the mfERG.for better or for worse?". Graefes Arch Clin Exp Ophthalmol (2002) 0.78
Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation. Ophthalmology (2013) 0.78
An analysis of the relationship between metastases and cachexia in lung cancer patients. Cancer Med (2016) 0.75